Skip to Content

CVRx Inc CVRX

Morningstar Rating
$18.21 +0.22 (1.22%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CVRX is trading at a 28% discount.
Price
$18.34
Fair Value
$16.97
Uncertainty
Very High
1-Star Price
$21.95
5-Star Price
$31.28
Economic Moat
Mbk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CVRX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$17.99
Day Range
$17.8618.60
52-Week Range
$8.3833.14
Bid/Ask
$17.85 / $18.58
Market Cap
$381.09 Mil
Volume/Avg
322,718 / 144,013

Key Statistics

Price/Earnings (Normalized)
Price/Sales
9.62
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
200

Comparables

Valuation

Metric
CVRX
NARI
ANIK
Price/Earnings (Normalized)
515.48
Price/Book Value
5.015.961.75
Price/Sales
9.625.522.23
Price/Cash Flow
81.8236.02
Price/Earnings
CVRX
NARI
ANIK

Financial Strength

Metric
CVRX
NARI
ANIK
Quick Ratio
12.482.433.50
Current Ratio
14.253.095.26
Interest Coverage
−21.82−56.99
Quick Ratio
CVRX
NARI
ANIK

Profitability

Metric
CVRX
NARI
ANIK
Return on Assets (Normalized)
−30.99%5.07%−1.35%
Return on Equity (Normalized)
−39.58%6.37%−1.65%
Return on Invested Capital (Normalized)
−32.19%3.35%−2.24%
Return on Assets
CVRX
NARI
ANIK
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesBwwxcsqkBygwzc$197.2 Bil
SYK
Stryker CorpMnccdqwvCqt$136.2 Bil
MDT
Medtronic PLCRtfsbttsVcmmp$115.7 Bil
BSX
Boston Scientific CorpQxykrvkvNckrx$100.7 Bil
EW
Edwards Lifesciences CorpXklgvqgstTnxvy$57.5 Bil
DXCM
DexCom IncWhhqzysnMvf$53.5 Bil
ZBH
Zimmer Biomet Holdings IncDfjmlpmmcYmgb$27.1 Bil
ALGN
Align Technology IncPnfcvymcRbsyc$24.6 Bil
PHG
Koninklijke Philips NV ADRFctzlvldtPvybyt$18.2 Bil
PODD
Insulet CorpHdfgbtxkFdhpddl$12.0 Bil

Sponsor Center